Boydsense
BOYDSense: Affordable, non-invasive biomarker measurement tools via exhaled breath.
BOYDSense: Affordable, non-invasive biomarker measurement tools via exhaled breath.
Founded in Toulouse, France, Boydsense is dedicated to creating non-invasive and affordable tools for measuring critical biomarkers through exhaled breath. The company's core mission is to revolutionize health monitoring by providing accessible and user-friendly diagnostic solutions. Boydsense's innovative technology aims to offer a painless alternative to traditional blood tests, making it easier for individuals to manage their health. Their primary market focus includes patients with chronic conditions such as diabetes, where continuous monitoring is crucial.
Boydsense has garnered attention from notable investors and industry experts who recognize the potential of their groundbreaking technology. The leadership team comprises experienced professionals in biotechnology and healthcare innovation. Key achievements include successful prototype development and initial clinical trials demonstrating the efficacy of their breath analysis technology. Boydsense's impact lies in its potential to transform health diagnostics, offering a more convenient and less invasive option for millions of patients worldwide.
Companies similar to Boydsense include Breath Diagnostics, Persperion Diagnostics, Metre and Biometry.
Boydsense was founded in 2015.
Boydsense's headquarters is located in South San Francisco, CA, US.
Boydsense's most recent funding round was for €2.5M (EUR) in January 2022.
As of Jan 6, 2022, Boydsense has disclosed funding of €2.5M (EUR). Undisclosed round amounts are excluded.
Boydsense has 33 employees as of Feb 4, 2024.
Biometry
mybiometry.com
